Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Interest Coverage Ratio (2020 - 2023)

Historic Interest Coverage Ratio for Relay Therapeutics (RLAY) over the last 4 years, with Q1 2023 value amounting to 33725.67.

  • Relay Therapeutics' Interest Coverage Ratio fell 102918.96% to 33725.67 in Q1 2023 from the same period last year, while for Dec 2023 it was 124333.33, marking a year-over-year decrease of 77244.17%. This contributed to the annual value of 91174.5 for FY2021, which is 251451.0% down from last year.
  • As of Q1 2023, Relay Therapeutics' Interest Coverage Ratio stood at 33725.67, which was down 102918.96% from 2986.71 recorded in Q1 2022.
  • In the past 5 years, Relay Therapeutics' Interest Coverage Ratio ranged from a high of 4373.5 in Q4 2020 and a low of 33725.67 during Q1 2023
  • Over the past 4 years, Relay Therapeutics' median Interest Coverage Ratio value was 7901.2 (recorded in 2020), while the average stood at 9563.49.
  • In the last 5 years, Relay Therapeutics' Interest Coverage Ratio surged by 6478.35% in 2022 and then tumbled by 102918.96% in 2023.
  • Over the past 4 years, Relay Therapeutics' Interest Coverage Ratio (Quarter) stood at 4373.5 in 2020, then tumbled by 293.92% to 8481.0 in 2021, then surged by 64.78% to 2986.71 in 2022, then tumbled by 1029.19% to 33725.67 in 2023.
  • Its Interest Coverage Ratio stands at 33725.67 for Q1 2023, versus 2986.71 for Q1 2022 and 8481.0 for Q1 2021.